The Global PET-CT
Scanner Device Market, by Detector Type (FluroDeoxyGlucose, 62CU ATSM,
FMISO, Gallium, Thallium, and Others), by Setting (Fixed and Portable), by
Application (Cardiology, Neurology, Oncology, and Others), by End User
(Hospitals, Diagnostic Centers, and Research Institutes), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was
valued at US$ 1.9 billion in 2017, and is projected to exhibit a CAGR of 5.1%
over the forecast period (2018 - 2026).
Reduction in price of PET-CT
scanners, increasing incidence of cancer, and rising clinical applications of
these devices are expected to drive the PET-CT scanner device market growth
over the forecast period. According to the American Cancer Society, cancer
incidence rates increased in children and adolescents by 0.6% per year since
1975. Cancer is the second most common cause of death among children of age 1
to 14 years in the U.S., after accidents. In 2018, an estimated 10,590 children
of this age group are expected to be diagnosed with cancer. Furthermore,
continued development of new radiotracers is expected to drive demand for
PET-CT scanners in clinical applications such as oncology, Alzheimer's disease
and others.
Technological advancements in
these devices include introduction of features such as high image contrast and
resolution, removal of metal artifacts, improved large field-of-view imaging,
and others. In 2017, Toshiba Medical launched new Celesteion PUREViSION Edition
PET-CT system to help diagnose and treat oncology patients. It offers 70 cm
true field-of-view, and SUREFLiGHT reconstruction technology, including Time of
Flight and Point Spread Function techniques, and offers high contrast and sharp
images to the oncologists for improved visualization of small tumors.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2169
Major advantages of the PET-CT
include better localization of activity to normal versus abnormal structures,
better identification of inflammatory lesions, overall decreased scan time,
discovery of serendipitous abnormalities, CT visualization of PET-negative
lesions, confirmation of abnormal or unusual sites, and improved localization
for radiotherapy or biopsy. Characterization and localization of lesions to
confirm or exclude malignancy is a very important aspect of these devices.
Browse 24 Market Data Tables and
29 Figures spread through 172 Pages and in-depth TOC on "PET-CT Scanner
Device Market, by Detector Type (FluroDeoxyGlucose, 62CU ATSM, FMISO, Gallium,
Thallium, and Others), by Setting (Fixed and Portable), by Application
(Cardiology, Neurology, Oncology, and Others), by End User (Hospitals,
Diagnostic Centers, and Research Institutes), and by Region (North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast
to 2026"
Manufacturers in the PET-CT
scanner device market are focusing on the development of technologically
advanced and low price devices. For instance, in 2016, Neusoft Medical Systems,
a Chinese medical device manufacturer, launched NeuSight PET-CT scanners,
globally. NeuSight PET/CT device received FDA approval in the U.S. and CE Mark
approval in the European Union in 2015. The device offers high quality
diagnostic images with fast processing speeds. High price of these devices was
one of the major factors hindering the imaging centers from purchasing PET-CT
scanners in previous years. In 2013, the cost of PET-CT machines was around US$
3 million. However, in recent years, price for PET-CT scanners have reduced to
US$ 1.5 million for entry-level machines, as vendors have developed lower-cost
options.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/pet-ct-scanner-device-market-2169
Key Takeaways of the PET-CT
Scanner Device Market:
The global PET-CT scanner device
market is expected to expand at a CAGR of 5.1% during the forecast period
(2018–2026), since the PET-CT combination allows for both the structure and the
biochemical processes to be shown in an image, which increased the demand for
PET-CT in oncology
Among application, oncology
segment is expected to account for major revenue share in 2018, owing to
increasing prevalence of various types of cancer. According to the American Cancer
Society 2018 report, in 2018, the overall estimated cancer cases are 1,735,350,
which is over 4,700 new cancer diagnosis daily.
Major players operating in the
global PET-CT scanner device market include General Electric Co., Hitachi,
Ltd., Mediso Ltd., Koninklijke Philips N.V., PerkinElmer, Inc., Positron
Corporation, Siemens AG, Shimadzu Corporation, Toshiba Corporation, and
Yangzhou Kindsway Biotech Co. Ltd.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2169
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment